Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.

NCT04381494 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
40
Enrollment
INDUSTRY
Sponsor class

Stopped Study was not terminated for any safety concerns; it was stopped early due to inability to enroll patients in a timely manner and retain patients on study for the entire duration

Conditions

Interventions

Sponsor

AstraZeneca